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Abstract Plasma and urinary levels of 8-iso-PGF2K and 15-
keto-dihydro-PGF2K were analysed at baseline and during the
ischemia-reperfusion period in experimental spinal cord ische-
mia. A significant and immediate increase of 8-iso-PGF2K in
plasma at the start and up to 60 min, and in the urine at 90^150
min following ischemia indicate an association of oxidative
injury. The inflammatory response indicator 15-keto-dihydro-
PGF2K in plasma increased significantly at the start and up to 60
min after ischemia. No such increase was seen in animals with no
spinal cord ischemia. Thus, free radical mediated and cyclo-
oxygenase catalysed products of arachidonic acid are increased
during spinal cord ischemia as a consequence of oxidative injury
and inflammation. ß 2001 Federation of European Biochemi-
cal Societies. Published by Elsevier Science B.V. All rights
reserved.
Key words: Ischemia-reperfusion; Prostaglandin;
Isoprostane; Spinal cord; Oxidative injury; In£ammation
1. Introduction
Spinal cord ischemia resulting in paraplegia remains the
most devastating complication following thoracoabdominal
aortic replacement [1]. Oxidative injury caused by lipid or
protein oxidation through intracellular free radical formation
is believed to contribute to ischemic-reperfusion injury [2,3].
The present hypothesis is whether experimental spinal cord
ischemia can cause any increase in the non-enzymatic and
enzymatic oxidative processes in the body.
Isoprostanes biosynthesised from arachidonic acid in vivo
mainly through non-enzymatic free radical catalysed oxidation
[4,5] and are elevated in several oxidant injury syndromes [4^
11]. Cyclooxygenase-2 (COX-2) has been shown to be ex-
pressed in various cells by several pro-in£ammatory stimuli
leading to the release of prostaglandins (PGs) [12,13]. 15-
Keto-dihydro-PGF2K, a major metabolite of PGF2K, is in-
creased in in£ammatory response and can be used as an in-
dicator of in vivo lipid peroxidation through the COX path-
way [14]. We have developed speci¢c radioimmunoassays
through raising antibodies against both 8-iso-PGF2K (a major
isoprostane indicating oxidative injury) and 15-keto-dihydro-
PGF2K (indicating in£ammatory response) [14,15]. By quanti-
fying these parameters, we have shown that oxidative modi¢-
cation of arachidonic acid is involved in hepatotoxicity [9],
septic shock [8,10], after cardiac arrest [16] and rheumatic dis-
eases [11]. This implicates that oxidative injury and in£amma-
tion are closely associated in these conditions but with di¡er-
ent kinetics of formation of arachidonic acid metabolites due
to diverse biochemical regulatory systems that are involved.
The goal of this study was to investigate oxidative injury
and in£ammatory response following spinal cord ischemia-re-
perfusion as measured by plasma and urinary 8-iso-PGF2K,
and plasma 15-keto-dihydro-PGF2K in a well-described model
of experimental ischemia-reperfusion in pigs. The grade of
ischemia was continuously monitored in cerebrospinal £uid
(CSF) by intrathecal PO2 and PCO2 correlated with the ultra-
structural changes in the spinal cord after clamping and de-
clamping of the descending aorta [17].
2. Materials and methods
2.1. Animal preparation and experimental model
The experiments were performed in 11 Swedish domestic pigs
weighing 23.3^37.4 kg. The experimental model was previously de-
scribed [17]. In brief, following general anaesthesia and surgical prep-
aration, a limited distal thoracic laminectomy was performed, and
over an arterial-needle introducer a multiparameter PO2, PCO2, pH
and temperature sensor (Paratrend 7) was introduced into the intra-
thecal space for continuous CSF monitoring of PO2, PCO2 and pH. A
plastic tube was inserted as an aortic shunt via the proximal left
subclavian artery close to the aortic arch and to the distal abdominal
aorta via proximal left common iliac artery. The thoracic aorta just
distal to the left subclavian artery was clamped and the distal aortic
perfusion was restored after 3 min through the aortic shunt. The right
subclavian artery was also clamped followed by interruption of all the
lumbar arteries with ligatures except for L1, and 3 min were allowed
for CSF recordings before placement of the distal aortic clamp below
the level of L1. Animals were divided into two groups depending on
the level of the distal aortic cross-clamping (DAXC): Group A (n = 8,
spinal cord ischemia): DAXC caudal to the level of L1 and perfusion
of only the visceral arteries through the aortic shunt; group B (n = 3,
no spinal cord ischemia): DAXC cranial to the level of T12 and
perfusion of the spinal cord (T12-L1) together with the visceral ar-
teries via the aortic shunt. DAXC was 60 min and was followed by a
1-h reperfusion period. Paratrend recordings were continuously ob-
tained during AXC and reperfusion. Central hemodynamic measure-
ments were also obtained before AXC, before declamping, 30 and 60
min after declamping. At the end of the declamping period, 1000 ml
isotonic saline (37‡C) were perfused followed by paraformaldehyde
(1%) and glutaraldehyde (2%) in Millonig (300 mOsm bu¡er) solution
with a pH of 7.4. During the perfusion procedure distal aorta below
L3 and all visceral arteries were clamped, giving the solution solely to
the organs supplied by intercostal, subclavian and carotid arteries.
The spinal cord specimens were then harvested from the cervical
and lower thoracic spinal cord through laminectomies. Study approv-
al was obtained from the local Ethics Committee of the Uppsala
University.
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2.2. Sample collection
Blood samples were collected from superior vena cava at the base-
line, after start of ischemia (aortic cross-clamping), 15, 30 and 60 min
after double cross-clamping and 30, 60 and 90 min after declamping
and reperfusion ( = 90, 120 and 150 min after start of ischemia). Uri-
nary samples were collected from the urinary bladder by a catheter at
the same time points as for the blood samples collection. Samples
were stored frozen at 370‡C until analysis.
2.3. Radioimmunoassays of 8-iso-PGF2K and 15-keto-dihydro-PGF2K
Plasma and/or urinary samples were analysed for 8-iso-PGF2K and
15-keto-dihydro-PGF2K by radioimmunoassay as described elsewhere
[14,15]. The cross-reactivity of the 8-iso-PGF2K antibody with 15-keto-
13,14-dihydro-8-iso-PGF2K, 8-iso-PGF2L, PGF2K, 15-keto-PGF2K,
15-keto-13,14-dihydro-PGF2K, thromboxane B2 (TXB2), 11L-PGF2K,
9L-PGF2K and 8-iso-PGF3K, respectively was 1.7, 9.8, 1.1, 0.01, 0.01,
0.1, 0.03, 1.8 and 0.6%. The detection limit of the assay was about 23
pmol/l. The cross-reactivity of the 15-keto-dihydro-PGF2K antibody
with PGF2K, 15-keto-PGF2K, PGE2, 15-keto-13,14-dihydro-PGE2,
8-iso-15-keto-13,14-dihydro-PGF2K, 11L-PGF2K, 9L-PGF2K, TXB2
and 8-iso-PGF3K was 0.02, 0.43, 6 0.001, 0.5, 1.7, 6 0.001,
6 0.001, 6 0.001, 0.01%, respectively. The detection limit of the assay
was about 45 pmol/l.
2.4. Statistical analysis
The results were expressed as mean þ S.D. A P value 6 0.05 was
considered to be signi¢cant. Di¡erences between the two groups were
calculated by an analysis of variance model (ANOVA) with factors
for treatment, pig and time point. These calculations were based on
the individual values for each pig at baseline ( = 0 h) and each time
point of measurement. For variables with skewed distributions, loga-
rithmic transformation was performed before statistical analysis.
3. Results
3.1. Oxidative injury as measured by plasma and urinary
8-iso-PGF2K
Baseline levels of 8-iso-PGF2K in the plasma and urine did
not di¡er between the groups. A signi¢cant di¡erence in the
concentration of 8-iso-PGF2K in both plasma and urine was
observed between groups A and B at various time points after
ischemia. 8-Iso-PGF2K increased signi¢cantly in plasma in an-
imals with spinal cord ischemia (group A) after the start of
clamping of the proximal and distal part of decending thora-
cic aorta (P = 0.03) and continued to be signi¢cantly higher
than the baseline values (P = 0.02 at 15 min; P = 0.03 at 30
min; P = 0.03 at 60 min) until 60 min of ischemia but not at
the following reperfusion period after declamping of the aorta
(Fig. 1). Similarly, the urinary concentration of 8-iso-PGF2K
increased signi¢cantly (P = 0.04 at 60 min; P = 0.0013 at 90
min; P = 0.0001 at 120 min; P = 0.0001 at 150 min after start
of ischemia) from 60 min to the end of the experiment at 150
min after the start of ischemia ( = 90 min after the start of
declamping of the aorta and reperfusion period) (Fig. 2). No
such di¡erence was found in the animals with no spinal cord
ischemia (group B). Neither there was a signi¢cant di¡erence
in plasma 8-iso-PGF2K levels during the reperfusion period
compared to the baseline values.
3.2. In£ammatory response as measured by plasma
15-keto-dihydro-PGF2K
Baseline levels of 15-keto-dihydro-PGF2K as an indicator of
primary PGF2K release in the plasma did not di¡er between
the groups. After clamping the thoracic aorta prostaglandin
metabolite levels increased in both groups (A and B) but with
di¡erent fashion and magnitude between the groups. The in-
crease was signi¢cant, much higher and longer in duration in
the animals (group A) with spinal cord ischemia (P = 0.006 at
the start ; P6 0.0001 at 15 min; P6 0.0001 at 30 min;
P = 0.04 at 60 min after the ischemia starts) compared to
Fig. 1. The levels of free 8-iso-PGF2K in peripheral plasma at di¡er-
ent times (p1 = baseline; p2 = aortic cross-clamping; p3, p4, p5 = 15,
30, 60 min after double cross-clamping; p6, p7, p8 = 30, 60, 90 min
after aortic declamping and reperfusion) in animals with or without
spinal cord ischemia (P values are denoted on the bars).
Fig. 3. The levels of 15-keto-dihydro-PGF2K in peripheral plasma at
di¡erent times (p1 = baseline; p2 = aortic cross-clamping; p3, p4,
p5 = 15, 30, 60 min after double cross-clamping; p6, p7, p8 = 30, 60,
90 min after aortic declamping and reperfusion) in animals with or
without spinal cord ischemia (P values are denoted on the bars).
Fig. 2. The urinary levels of free 8-iso-PGF2K in animals at di¡erent
times (p1 = baseline; p2 = aortic cross-clamping; p3, p4, p5 = 15, 30,
60 min after double cross-clamping; p6, p7, p8 = 30, 60, 90 min
after aortic declamping and reperfusion) with or without spinal cord
ischemia (P values are denoted on the bars).
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the animals (group B) with no spinal cord ischemia (P = 0.005
at 15 min after start of ischemia) (Fig. 3). No signi¢cant in-
crease of plasma 15-keto-dihydro-PGF2K was observed during
the reperfusion period after declamping of the thoracic aorta
in either of the groups.
4. Discussion
This study describes a rapid appearance of oxidative stress
and in£ammatory response caused by cross-clamping of the
thoracic aorta to achieve an experimental spinal cord ische-
mia. Since free radicals are involved in the oxidative injury
which might cause enhanced lipid peroxidation [16] this study
investigates the role of lipid peroxidation in spinal cord ische-
mia-reperfusion. To our knowledge, this report is the earliest
to describe an increase of both isoprostane and prostaglandin
formation during spinal cord ischemia. It demonstrated that
both 8-iso-PGF2K and 15-keto-dihydro-PGF2K in the plasma
are increased instantly and continued during 60 min of the
ischemic period indicating an association of oxidative stress
and in£ammation during the clamping of the proximal and
distal descending thoracic aorta. When urinary 8-iso-PGF2K
was taken into consideration as an indication of excretion of
8-iso-PGF2K, an excellent correlation was found between the
plasma and urinary measurement of this compound due to a
small time di¡erence in the appearance and disappearance in
blood and urine which corroborates with previous studies
[9,18]. These indicate that both free radical and COX medi-
ated oxidation take place immediately after an ischemia which
further proves that involvement of free radical and COX cat-
alysation of arachidonic acid is a rapid process when an ob-
struction of the major spontaneous circulation is achieved.
Those animals who did not achieve spinal cord ischemia
might su¡ered of surgical trauma as evidenced by a mild
rise of 15-keto-dihydro-PGF2K metabolite in plasma at 15
min after aortic double cross-clamping.
We have previously reported that the oxidative stress pa-
rameter 8-iso-PGF2K arose in the circulation within 2 h in rats
after oral administration of CCl4 and which was followed by
in£ammatory PGF2K release [9]. In experimental septic shock,
PGF2K levels increased within half-an hour which was fol-
lowed by an increase of 8-iso-PGF2K [8,10]. However, this
study shows that both the oxidative stress and in£ammatory
response parameters appear instantly in plasma and continue
to release during the whole ischemic period and slowly re-
turned to their basal levels at the end of the reperfusion peri-
od. A rapid increase of both F2-isoprostanes and PGF2K me-
tabolite levels in plasma has also been shown following
resuscitation after cardiac arrest [16]. Together, it indicates
that by shunting major aorta the induction of free radicals
related reactions in body appear to be an instant process.
Thus, although the oxidative stress and in£ammatory re-
sponse are closely linked the kinetics of appearance and dis-
appearance of free radical induced or COX catalysed oxida-
tive state is a process which mainly depends on the type of
insult that body had experienced.
The cross-reactivity of 15-keto-dihydro-PGF2K to 8-iso-
PGF2K antibody is only 0.01%. However, in this study we
have seen that the levels of 15-keto-dihydro-PGF2K increased
about 10 times more than the levels of 8-iso-PGF2K in plasma
at time points 15, 30, 60 min after aortic double cross-clamp-
ing in the spinal cord ischemia group. These increases of 8-iso-
PGF2K at these time points are not due to the cross-reactivity
of the 8-iso-PGF2K antibody by the 15-keto-dihydro-PGF2K
levels in the plasma as evidenced by our recent study where
induction of PGF2K formation by conjugated linoleic acid is
inhibited by COX-2 inhibitor but not the induction of 8-iso-
PGF2K formation [19]. This indicates that even if the levels of
15-keto-dihydro-PGF2K arise an order of magnitude above
those of F2-isoprostane in this study the cross-reactivity of
0.01% (8-iso-PGF2K antibody to 15-keto-dihydro-PGF2K)
does not a¡ect the levels of isoprostanes.
In conclusion, free radical and COX catalysed oxidation of
arachidonic acid are involved in spinal cord ischemia. En-
hanced oxidative injury and in£ammatory response as dem-
onstrated by a rapid increase of both 8-iso-PGF2K and 15-
keto-dihydro-PGF2K in the body £uids play an eminent role
in spinal cord ischemia and thus can be used as biomarkers of
ischemic injury in the spinal cord.
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